ChemoradiotherapyCombined Modality TherapyRadiotherapy DosageRadiotherapyAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, Intensity-ModulatedCisplatinRadiotherapy, ConformalRadiotherapy, AdjuvantDose FractionationChemotherapy, AdjuvantNasopharyngeal NeoplasmsCarcinoma, Squamous CellFluorouracilHead and Neck NeoplasmsNeoplasm StagingTreatment OutcomeChemoradiotherapy, AdjuvantRadiation InjuriesDisease-Free SurvivalEsophagitisMucositisEsophageal NeoplasmsNeoadjuvant TherapyLung NeoplasmsSurvival RateRadiotherapy Planning, Computer-AssistedCarboplatinSurvival AnalysisAntineoplastic AgentsCarcinoma, Non-Small-Cell LungRadiotherapy, High-EnergyInduction ChemotherapyNeoplasm Recurrence, LocalDrug Administration ScheduleRetrospective StudiesPaclitaxelKaplan-Meier EstimateBrachytherapyPrognosisFollow-Up StudiesUterine Cervical NeoplasmsEtoposideOrgans at RiskTaxoidsHypopharyngeal NeoplasmsRadiation PneumonitisDose-Response Relationship, RadiationLaryngeal NeoplasmsAdenocarcinomaRectal NeoplasmsDeoxycytidineOropharyngeal NeoplasmsRadiation-Sensitizing AgentsAntimetabolites, AntineoplasticProton TherapyOxonic AcidAnus NeoplasmsTegafurDeglutition DisordersRemission InductionFeasibility StudiesPharyngectomyThoracic NeoplasmsCarcinoma, Small CellTreatment FailureTime FactorsEsophagectomyNeoplasms, Squamous CellRadiotherapy, Image-GuidedPositron-Emission TomographyOrgan Sparing TreatmentsRadiotherapy, Computer-AssistedCarcinomaLymphatic MetastasisRadiation OncologyCyclophosphamideDoxorubicinNeoplasm MetastasisRadiometryBrain NeoplasmsRandomized Controlled Trials as TopicRadiation DosageBreast NeoplasmsPelvic NeoplasmsOrganoplatinum CompoundsVinblastineTomography, X-Ray ComputedParticle AcceleratorsPreoperative CareSalvage TherapyProspective StudiesLymphatic IrradiationCranial IrradiationAntineoplastic Agents, AlkylatingDacarbazineNeoplasmsPancreatic NeoplasmsRadiation ToleranceMethotrexate